HUMAW
Income statement / Annual
Last year (2023), Humacyte, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Humacyte, Inc.'s net income was -$110.78 M.
See Humacyte, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$1.57 M
|
$1.26 M
|
$1.49 M
|
$6.19 M
|
| Cost of Revenue |
$76.55 M |
$8.26 M |
$49,000.00 |
$8.43 M |
$75.60 M |
| Gross Profit |
-$76.55 M |
-$6.69 M |
$1.21 M |
-$6.94 M |
-$69.42 M |
| Gross Profit Ratio |
0 |
-4.27 |
0.96 |
-4.66 |
-11.22 |
| Research and Development
Expenses |
$76.55 M
|
$63.26 M
|
$61.34 M
|
$54.08 M
|
$75.60 M
|
| General & Administrative
Expenses |
$23.39 M
|
$22.88 M
|
$21.13 M
|
$12.01 M
|
$16.27 M
|
| Selling & Marketing
Expenses |
-$3.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$20.39 M
|
$22.88 M
|
$21.13 M
|
$12.01 M
|
$16.27 M
|
| Other Expenses |
-$73.44 M |
-$1.57 M |
-$1.26 M |
-$1.49 M |
$0.00 |
| Operating Expenses |
$23.50 M |
$84.58 M |
$81.21 M |
$64.60 M |
$16.28 M |
| Cost And Expenses |
$100.05 M |
$84.58 M |
$81.21 M |
$64.60 M |
$91.88 M |
| Interest Income |
$0.00 |
$2.63 M |
$16,000.00 |
$278,000.00 |
$269,000.00 |
| Interest Expense |
$1.13 M |
$6.20 M |
$4.35 M |
$2.20 M |
$2.30 M |
| Depreciation &
Amortization |
$7.72 M
|
$8.26 M
|
$8.28 M
|
$8.43 M
|
$6.75 M
|
| EBITDA |
-$96.46 M
|
$2.49 M
|
-$72.97 M
|
-$56.25 M
|
-$78.94 M
|
| EBITDA Ratio |
0 |
-102.46 |
-108.46 |
-37.54 |
-12.76 |
| Operating Income Ratio
|
0
|
-54.04
|
-64.3
|
-43.33
|
-13.85
|
| Total Other
Income/Expenses Net |
-$10.73 M
|
$72.61 M
|
$54.73 M
|
-$1.92 M
|
$269,000.00
|
| Income Before Tax |
-$110.78 M |
-$11.97 M |
-$26.48 M |
-$66.52 M |
-$85.42 M |
| Income Before Tax Ratio
|
0
|
-7.65
|
-20.96
|
-44.62
|
-13.81
|
| Income Tax Expense |
$0.00 |
-$76.18 M |
-$64.01 M |
$2.20 M |
$0.00 |
| Net Income |
-$110.78 M |
$64.22 M |
$37.54 M |
-$68.73 M |
-$85.42 M |
| Net Income Ratio |
0 |
41.03 |
29.72 |
-46.09 |
-13.81 |
| EPS |
-1.07 |
0.62 |
0.94 |
-5.52 |
-4.25 |
| EPS Diluted |
-1.07 |
0.62 |
0.94 |
-5.52 |
-4.25 |
| Weighted Average Shares
Out |
$103.42 M
|
$103.05 M
|
$39.97 M
|
$12.45 M
|
$20.12 M
|
| Weighted Average Shares
Out Diluted |
$103.42 M
|
$103.05 M
|
$39.97 M
|
$12.45 M
|
$20.12 M
|
| Link |
|
|
|
|
|
